| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |